Vetoquinol Defies Market Trends: How This Animal Health Giant Outperformed in a Flat 2023 Market
My Vet Candy My Vet Candy

Vetoquinol Defies Market Trends: How This Animal Health Giant Outperformed in a Flat 2023 Market

Matthieu Frechin, Chairman and CEO of Vetoquinol (Paris:VETO), has announced a remarkable performance in a challenging 2023 animal health market, attributing the company's resilience and agility to its success. Despite flat market volumes, Vetoquinol's 2023 sales were buoyed by the strong showing of their Essentials product line in the latter half of the year, demonstrating sustained growth and operational efficiency

Read More
PetVivo Holdings, Inc. Announces Release of Clinical Study Results Involving Canine Tolerance to Intra-articular Injections of Spryng™ with OsteoCushion™ Technology
My Vet Candy My Vet Candy

PetVivo Holdings, Inc. Announces Release of Clinical Study Results Involving Canine Tolerance to Intra-articular Injections of Spryng™ with OsteoCushion™ Technology

“We were pleased to have the release of the final results of this Spryng tolerance study as this data demonstrates the safety of this veterinary medical device when injected into the joints of dogs,” said John Lai, Chief Executive Officer of PetVivo Holdings, Inc. “We continue to strive to provide data demonstrating that Spryng is a viable tool to use in the management of joint related afflictions that thereby enhances the lives of companion animals and their owners.”

Read More